How the product works:
- Sofosbuvir inhibits NS5B polymerase, preventing viral RNA replication
- Velpatasvir targets NS5A protein, disrupting viral lifecycle
- Works against all 6 major HCV genotypes
- Achieves SVR (cure) rates of up to 98%
- Effective in cases of cirrhosis, HIV co-infection, or treatment failure
Recommended for:
- Patients with chronic HCV infection (any genotype)
- Individuals with liver fibrosis or cirrhosis
- HIV-positive patients co-infected with HCV
- Previously untreated or treatment-failed cases
- Those seeking simplified, single-tablet therapy
Array
(
[actionUrl] => [[+assetsUrl]]action.php
[form] => admin@sacred-leaves.com,idrees@sacred-leaves.com,info@sacred-leaves.com
[formSelector] => ajax_form
[frontend_css] => [[+assetsUrl]]css/default.css
[frontend_js] => [[+assetsUrl]]js/default.js
[objectName] => AjaxForm
[snippet] => FormIt
[hooks] => email
[emailTpl] => tpl.simple-email
[emailSubject] => Сообщение с сайта
[emailTo] => verfut@yandex.ru
[validate] => username:required, tel:required
[validationErrorMessage] => В форме содержатся ошибки!
[successMessage] => Сообщение успешно отправлено
)